Mano Michael 4
4 · Karyopharm Therapeutics Inc. · Filed Sep 5, 2024
Insider Transaction Report
Form 4
Mano Michael
EVP, CLO&Secretary
Transactions
- Sale
Common Stock
2024-09-04$0.72/sh−3,971$2,866→ 273,881 total
Footnotes (1)
- [F1]This transaction was effected pursuant to a durable automatic sale instruction plan adopted by the reporting person on May 16, 2022, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units. The sale does not represent a discretionary trade by the reporting person.